SCHEMBL6837534

SCHEMBL6837534

COc1ccccc1NC(=O)c1cc2c(CNC3CCCCCCC3)ccc(OC)c2o1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.54
MEN1 O00255 4/20 0.54
THRB P10828 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
PDE4A P27815 1/20 0.46
PDE4B Q07343 1/20 0.46
PDE4C Q08493 1/20 0.46
PDE4D Q08499 1/20 0.46
RXFP1 Q9HBX9 1/20 0.45
GAA P10253 2/20 0.43
LMNA P02545 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
TSHR P16473 2/20 0.42
KDM4E B2RXH2 2/20 0.42
HSD17B10 Q99714 1/20 0.42
HTT P42858 1/20 0.42
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6836842 0.97 KMT2A (0.52) KMT2AMEN1THRBSMN1; SMN2NPC1
SCHEMBL6837518 0.90 PDE4A (0.49) KMT2AMEN1PDE4APDE4BPDE4C
SCHEMBL6836480 0.90 PDE4A (0.49) KMT2AMEN1PDE4APDE4BPDE4C
SCHEMBL6837598 0.89 PDE4A (0.50) KMT2AMEN1PDE4APDE4BPDE4C
SCHEMBL6837529 0.87 PDE4A (0.48) KMT2AMEN1SMN1; SMN2RAB9APDE4A
SCHEMBL6837984 0.86 MEN1 (0.48) KMT2AMEN1NPC1RAB9AL3MBTL1
SCHEMBL6837591 0.86 MEN1 (0.48) KMT2AMEN1NPC1RAB9AL3MBTL1
SCHEMBL6837851 0.86 MEN1 (0.48) KMT2AMEN1NPC1RAB9AL3MBTL1
SCHEMBL6837639 0.86 MEN1 (0.48) KMT2AMEN1NPC1RAB9AL3MBTL1
SCHEMBL6839429 0.86 MEN1 (0.47) KMT2AMEN1SMN1; SMN2L3MBTL1PDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6716987-B1 PHOSPHODIESTERASE IV INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 2004-04-06 US disclosed
US-6514996-B2 Derivatives of benzofuran or benzodioxole KYOWA HAKKO KOGYO CO., LTD. (JP) 2003-02-04 US disclosed
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE KYOWA HAKKO KOGYO CO., LTD. (JP) 2002-09-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE CBR1, CBR3, CYC1 KMT2A 4289/4885MEN1 4379/4885THRB 1933/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.